U.S. stock futures were mixed this morning, with the Dow futures gaining around 0.1% on Wednesday.

Shares of Intuit Inc (NASDAQ:INTU) fell sharply in pre-market trading after the company reported upbeat fourth-quarter financial results but issued FY27 guidance below estimates.

Intuit reported fourth-quarter revenue of $4.35 billion, beating analyst estimates of $4.27 billion. The QuickBooks, Credit Karma and TurboTax parent company posted adjusted earnings of $4.03 per share for the quarter, beating estimates of $3.58 per share, according to Benzinga Pro.

Intuit expects fiscal 2027 revenue of $23.28 billion to $23.51 billion versus estimates of $23.74 billion. The company expects full-year adjusted earnings of 22.88 to $23.12 per share versus estimates of $27.31 per share. The earnings guidance includes a $5.81 impact from share-based compensation expenses, so estimates may not be comparable. Intuit also noted that Mailchimp will become a separate reportable segment beginning in fiscal 2027.

Intuit shares dipped 11.7% to $315.50 in pre-market trading.

Here are some other stocks moving lower in pre-market trading.

• Advasa Holdings (NASDAQ:ADBT) shares dipped 14.1% to $5.38 in pre-market trading after dipping around 48% on Tuesday. Advasa Holdings, on Tuesday, completed a direct listing on Nasdaq under the ticker symbol “ADBT”.
• Spyre Therapeutics Inc (NASDAQ:SYRE) declined 12.3% to $94.16 in pre-market trading after the company announced topline results from the RA sub-study of its Phase 2 SKYWAY basket trial evaluating SPY072 in rheumatic diseases. The results did not meet the company’s internal bar to prioritize advancement of SPY072 in RA.
• Qfin Holdings Inc – ADR (NASDAQ:QFIN) dropped 9.8% to $10.40 in pre-market trading after the company reported a year-over-year decrease in second-quarter financial results.
• Digital Currency X Technology Inc (NASDAQ:DCX) fell 7.5% to $0.90 in pre-market trading following a 2% decline on Tuesday.
• Ultrapar Participacoes SA (NYSE:UGP) fell 6% to $6.30 in pre-market trading.
• Zoom Communications Inc (NASDAQ:ZM) fell 5.8% to $95.10 in pre-market trading as the company reported better-than-expected financial results for the second quarter but issued soft guidance for the third quarter.
• Frontline Plc (NYSE:FRO) fell 5% to $41.32 in pre-market trading.
• SAP SE (NYSE:SAP) declined 4.6% to $207.00 in pre-market trading.
• BioCryst Pharmaceuticals Inc (NASDAQ:BCRX) declined 4.3% to $9.41 in pre-market trading. BioCryst, on Tuesday, announced the approval of ORLADEYO for pediatric HAE patients in Japan.
• BW LPG Ltd (NYSE:BWLP) fell 4.1% to $23.79 in pre-market trading after gaining around 5% on Tuesday.

Photo via Shutterstock